Summary
Aphidicolin, a specific inhibitor of DNA polymerase α, is known to induce chromosomal aberrations. At concentrations that did not greatly affect mitotic index, aphidicolin induced a striking number of chromosome gaps and breaks distributed in a highly nonrandom manner in cultured human lymphocytes. Specific chromosome bands, especially 2q31, 3p14, 6q26, 7q32, 16q23, and Xp22 were preferentially damaged in lymphocytes from each of 12 subjects studied. Total and site-specific damage was dose dependent and greatly increased when folic acid was removed from the medium. The sites most sensitive to aphidicolin damage include the “hot spots” seen under conditions of thymidylate stress and in studies of spontaneous chromosomal damage. The fragile X site, which can also be induced by thymidylate stress, was not induced by aphidicolin in lymphocytes, suggesting a separate mechanism for its induction. Aphidicolin represents a novel tool for detection of hot spots on human chromosomes through the mechanism of DNA polymerase α inhibition. The hot spots induced by aphidicolin represent a new class of fragile sites which we term common fragile sites.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aula P, von Koskull H (1976) Distribution of spontaneous chromosome breaks in human chromosomes. Hum Genet 32:143–148
Ayme S, Mattei JF, Mattei MG, Aurran Y, Giraud F (1976) Nonrandom distribution of chromosome breaks in cultured lymphocytes of normal subjects. Hum Genet 31:161–175
Bender MA, Preston RJ (1981) Role of base damage in aberration formation, interaction of aphidicolin and X-rays. In: Natarajan AT, Obe G, Altman H (eds) Progress in mutation research, vol 4. Elsevier Biomedical, Amsterdam, pp 37–46
Brøgger A (1975) Is the chromatid gap a folding defect due to protein change? Evidence from mercaptoethanol treatment of human lymphocyte chromosomes. Hereditas 80:131–136
Ciarrocchi G, Jose JG, Lin S (1979) Further characterization of a cell-free system for measuring replicative and repair DNA synthesis with cultured human fibroblasts and evidence for the involvement of DNA polymerase α in DNA repair. Nucleic Acids Res 7:1205–1219
DePamphilis ML, Wassarman PM (1980) Replication of eukaryotic chromosomes: A close-up of the replication fork. Annu Rev Biochem 49:627–666
Deugau KV, van de Sande JH, Lin CC (1978) A double intercalating analogue of quinacrine for chromosome banding. Am J Hum Genet 30:78A
Glover TW (1981) FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition. Am J Hum Genet 33:234–242
Hanoka F, Kata H, Ikegami S, Ohashi M, Yamoda M (1979) Aphidicolin does inhibit repair replication in HeLa cells. Biochem Biophys Res Commun 87:575–580
Hecht F, Sutherland GR (to be published) Fragile sites and cancer breakpoints. Cancer Genet Cytogenet
Huang Y, Chang CC, Trosko J (1983) Aphidicolin-induced endoreduplication in Chinese hamster cells. Cancer Res 43:1361–1364
Ikegami S, Taguchi T, Ohashi M, Oguro M, Nagano H, Mano Y (1978) Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase α. Nature 275:458–460
ISCN (1981) An international system for human cytogenetic nomenclature-high resolution banding. Cytogenet Cell Genet 31:1–23
Jacobs PA, Funkhouser J, Matsuura J (1981) Mutations of human chromosomes. In: Hook EB, Porter IH (eds) Population and biological aspects of human mutation. Academic Press, New York, pp 147–164
Krumdieck CL, Howard-Peebles PN (1983) On the nature of folic acid-sensitive fragile sites in human chromosomes: an hypothesis. Am J Med Genet 16:23–28
Kunz BA (1982) Genetic effects of deoxyribonucleotide pool imbalances. Environ Mutagen 4:695–725
Lonn U, Lonn S (1983) Aphidicolin inhibits the synthesis and joining of short DNA fragments but not the union of 10-kilobase DNA replication intermediates. Proc Natl Acad Sci USA 80:3996–3999
Lubs HA, Samuelson J (1967) Chromosome abnormalities in lymphocytes from normal human subjects. A study of 3720 cells. Cytogenetics 6:402–411
Mattei MG, Mattei JF, Vidal I, Giraud F (1981) Expression in lymphocyte and fibroblast culture of the fragile X chromosome: a new technical approach. Hum Genet 59:166–169
Nicander B, Richard P (1981) Aphidicolin sensitivity of variant 3T6 cells selected for changes in ribonucleotide reductase. Biochem Biophys Res Commun 103:148–155
Palmer CG (1981) Are there “hot spots” in the human genome? Evidence from breakpoint analysis in a collaborative study of germinal chromosome rearrangements. In: Hook EB, Porter IH (eds) Population and biological aspects of human mutation. Academic Press, New York, pp 147–164
Pedrali-Noy G, Spadari S (1980) Aphidicolin allows a rapid and simple evaluation of DNA-repair synthesis in damaged human cells. Mutat Res 70:389–394
Pedrali-Noy G, Spardari S, Miller-Faures A, Miller AOA, Kruppa J, Koch G (1980) Synchronization of HeLa cell cultures by inhibition of DNA polymerase α with aphidicolin. Nucleic Acids Res 8:377–387
Reddy GPV, Pardee AB (1983) Inhibitor evidence for allosteric interaction in the replitase multienzyme complex. Nature 304:86–88
Rudduck C, Franzen G (1983) A new heritable fragile site on human chromosome 3. Hereditas 98:297–299
Shabtai F, Klar D, Nissimov R, Vardimon D, Hart J, Halbrecht I (1983) A new familial “fragile site” on chromosome 16 (q23–q24). Cytogenetic and clinical considerations. Hum Genet 64:273–276
Smith PJ, Patterson MC (1983) Effect of aphidicolin on de novo DNA repair and cytotoxicity in γ-irradiated human fibroblasts. Implications for the enhanced radiosensitivity in ataxia telangiectasia. Biochim Biophys Acta 739:17–26
Snyder RD, Regan JD (1981) Aphidicolin inhibits repair of DNA in UV-irradiated human fibroblasts. Biochem Biophys Res Commun 99:1088–1094
Sutherland GR (1979) Heritable fragile sites on human chromosomes. I. Factors affecting expression in lymphocyte culture. Am J Hum Genet 31:125–135
Sutherland GR (1982) Heritable fragile sites on human chromosomes. VIII. Preliminary population cytogenetic data on the folic acid-sensitive fragile sites. Am J Hum Genet 34:452–458
Sutherland GR (1983) The fragile X chromosome. Int Rev Cytol 81:107–143
Tommerup N, Poulsen H, Brøndum-Nielsen K (1981) 5-Fluoro-2′-deoxyuridine induction of the fragile site on Xq28 associated with X-linked mental retardation. J Med Genet 18:374–376
van Zeeland AA, Bussman CJM, Degrassi F, Filon AR, van Kesterenvan Leeuwen AC, Palitti F, Natarajan AT (1982) Effects of aphidicolin on repair replication and induced chromosomal aberrations in mammalian cells. Mutat Res 92:379–392
von Koskull H, Aula P (1973) Nonrandom distribution of chromosome breaks in Fanconi's anemia. Cytogenet Cell Genet 12:423–434
Wegner R-D (1983) A new inducible fragile site on chromosome 3 (p14.2) in human lymphocytes. Hum Genet 63:297–298
Whang-Peng J, Benn PA, Kao-Shen CS, Lee EC, Carney DN, Gazdar A, Minn JD (1982) A nonrandom chromosomal abnormality, del 3p(14–23), in human small cell lung cancer. Cancer Genet Cytogenet 6:119–134
Yagura T, Kozu T, Seno T (1982) Arrest of chain growth of repliconsized intermediates by aphidicolin during rat fibroblast cell chromosome replication. Eur J Biochem 123:15–21
Yunis JJ (1983) The chromosomal basis of human neoplasia. Science 221:227–240
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Glover, T.W., Berger, C., Coyle, J. et al. DNA polymerase α inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet 67, 136–142 (1984). https://doi.org/10.1007/BF00272988
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00272988